MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
RNTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Rein Therapeutics (RNTX) Ownership - Who owns Rein Therapeutics?

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
12407 North Mopac Expressway
Phone
+1 737 802-1989
Employees
10
Web
https://www.reintx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
67.72M
P/E Ratio
N/A
Total Cash
40.65M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.92
Dividend Yield
N/A
Total Cash/Share
0.47
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
RNTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for RNTX
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
12407 North Mopac Expressway
Phone
+1 737 802-1989
Employees
10
Web
https://www.reintx.com
Who owns Rein Therapeutics? RNTX symbol Ownership - Tickeron.com